{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:25Z","timestamp":1707524905495},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"DOI":"10.7759\/cureus.34163","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T20:50:38Z","timestamp":1674593438000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Safety of Ultra-Low-Dose Estrogen Contraception in Sickle Cell Trait With Focus on Cerebral Venous Sinus Thrombosis"],"prefix":"10.7759","author":[{"given":"Cameron","family":"Kahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Kronen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameen","family":"Fahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3578","article-title":"Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis","volume":"107","author":"Dentali F","year":"2006","unstructured":"Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006, 107:2766-73. 10.1182\/blood-2005-09-3578","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003989.pub5","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception","volume":"2013","author":"Gallo MF","year":"2013","unstructured":"Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013, 2013:10.1002\/14651858.CD003989.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp S","year":"2000","unstructured":"Middeldorp S, Meijers JC, van den Ende A, et al.. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Thromb Haemost. 2000, 84:4-8. 10.1055\/s-0037-1613958","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans G","year":"2000","unstructured":"Tans G, Curvers J, Middeldorp S, et al.. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thromb Haemost. 2000, 84:15-21. 10.1055\/s-0037-1613960","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115799","article-title":"Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease","volume":"133","author":"Gerstman BB","year":"1991","unstructured":"Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol. 1991, 133:32-7. 10.1093\/oxfordjournals.aje.a115799","journal-title":"Am J Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal FR","year":"2002","unstructured":"Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol. 2002, 22:201-10. 10.1161\/hq0202.102318","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Weill A","year":"2016","unstructured":"Weill A, Dalichampt M, Raguideau F, et al.. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ. 2016, 353:10.1136\/bmj.i2002","journal-title":"BMJ"},{"key":"ref8","unstructured":"LOESTRIN\u00ae 21 (norethindrone acetate and ethinyl estradiol tablets, USP). (2013). https.\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/017354s045lbl.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin H","year":"2007","unstructured":"Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, Hooper WC. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007, 110:908-12. 10.1182\/blood-2006-11-057604","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom AR","year":"2015","unstructured":"Folsom AR, Tang W, Roetker NS, et al.. Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost. 2015, 13:2-9. 10.1111\/jth.12787","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012665","article-title":"Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis","volume":"7","author":"Little I","year":"2017","unstructured":"Little I, Vinogradova Y, Orton E, Kai J, Qureshi N. Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis. BMJ Open. 2017, 7:10.1136\/bmjopen-2016-012665","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap JJ","year":"2018","unstructured":"Noubiap JJ, Temgoua MN, Tankeu R, Tochie JN, Wonkam A, Bigna JJ. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis. Thromb J. 2018, 16:10.1186\/s12959-018-0179-z","journal-title":"Thromb J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2009.01.038","article-title":"Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women","volume":"200","author":"Austin H","year":"2009","unstructured":"Austin H, Lally C, Benson JM, Whitsett C, Hooper WC, Key NS. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol. 2009, 200:620.e1-3. 10.1016\/j.ajog.2009.01.038","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrnm.2018.02.002","article-title":"Risk of cerebral venous thrombosis in oral contraceptives pills users","volume":"49","author":"Ibrahim NM","year":"2018","unstructured":"Ibrahim NM, El-Shahawy AS, Elshabacy A. Risk of cerebral venous thrombosis in oral contraceptives pills users. Egypt J Radiol Nucl Med. 2018, 49:727-31. 10.1016\/j.ejrnm.2018.02.002","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref15","article-title":"Cerebral venous and sinus thrombosis: incidence and causes","volume":"92","author":"Stam J","year":"2003","unstructured":"Stam J. Cerebral venous and sinus thrombosis: incidence and causes. Adv Neurol. 2003, 92:225-32.","journal-title":"Adv Neurol"},{"key":"ref16","article-title":"Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis","volume":"4","author":"Ferro JM","year":"2006","unstructured":"Ferro JM. Causes, predictors of death, and antithrombotic treatment in cerebral venous thrombosis. Clin Adv Hematol Oncol. 2006, 4:732-3.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik G","year":"2011","unstructured":"Saposnik G, Barinagarrementeria F, Brown RD Jr, et al.. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011, 42:1158-92. 10.1161\/STR.0b013e31820a8364","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013617","article-title":"Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study","volume":"47","author":"Devasagayam S","year":"2016","unstructured":"Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016, 47:2180-2. 10.1161\/STROKEAHA.116.013617","journal-title":"Stroke"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.7.1537","article-title":"Isolated intracranial hypertension as the only sign of cerebral venous thrombosis","volume":"53","author":"Biousse V","year":"1999","unstructured":"Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999, 53:1537-42. 10.1212\/wnl.53.7.1537","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro JM","year":"2004","unstructured":"Ferro JM, Canh\u00e3o P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004, 35:664-70. 10.1161\/01.STR.0000117571.76197.26","journal-title":"Stroke"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042354","article-title":"Thrombosis of the cerebral veins and sinuses","volume":"352","author":"Stam J","year":"2005","unstructured":"Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005, 352:1791-8. 10.1056\/NEJMra042354","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.18.3.656","article-title":"Superior sagittal sinus thrombosis with infarction in sickle cell trait","volume":"18","author":"Feldenzer JA","year":"1987","unstructured":"Feldenzer JA, Bueche MJ, Venes JL, Gebarski SS. Superior sagittal sinus thrombosis with infarction in sickle cell trait. Stroke. 1987, 18:656-60. 10.1161\/01.str.18.3.656","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.484089","article-title":"Are steroids useful to treat cerebral venous thrombosis?","volume":"39","author":"Canh\u00e3o P","year":"2008","unstructured":"Canh\u00e3o P, Cortes\u00e3o A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F. Are steroids useful to treat cerebral venous thrombosis?. Stroke. 2008, 39:105-10. 10.1161\/STROKEAHA.107.484089","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12005","article-title":"Optic nerve sonography to monitor treatment efficacy in idiopathic intracranial hypertension: a case report","volume":"23","author":"Lochner P","year":"2013","unstructured":"Lochner P, Nardone R, Tezzon F, Coppo L, Brigo F. Optic nerve sonography to monitor treatment efficacy in idiopathic intracranial hypertension: a case report. J Neuroimaging. 2013, 23:533-4. 10.1111\/jon.12005","journal-title":"J Neuroimaging"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.19.7.903","article-title":"Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension","volume":"19","author":"Hanley DF","year":"1988","unstructured":"Hanley DF, Feldman E, Borel CO, Rosenbaum AE, Goldberg AL. Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke. 1988, 19:903-9. 10.1161\/01.str.19.7.903","journal-title":"Stroke"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.030800","article-title":"Incidence and mortality of cerebral venous thrombosis in a Norwegian population","volume":"51","author":"Kristoffersen ES","year":"2020","unstructured":"Kristoffersen ES, Harper CE, Vetvik KG, Zarnovicky S, Hansen JM, Faiz KW. Incidence and mortality of cerebral venous thrombosis in a Norwegian population. Stroke. 2020, 51:3023-9. 10.1161\/STROKEAHA.120.030800","journal-title":"Stroke"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129206-evaluating-the-safety-of-ultra-low-dose-estrogen-contraception-in-sickle-cell-trait-with-focus-on-cerebral-venous-sinus-thrombosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:36Z","timestamp":1707508656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129206-evaluating-the-safety-of-ultra-low-dose-estrogen-contraception-in-sickle-cell-trait-with-focus-on-cerebral-venous-sinus-thrombosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.34163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}